To view this email as a web page, click here.

 
From all of us at Dermatology Times: Thank you for trusting us for your industry news. We wish you a very happy and successful New Year!
 
A 1,854% Rx price hike
A recent review shows the cost of doxycycline hyclate rose significantly in two years and there was no association between market concentration and price of the oral antibiotic.
Read more.
 
A noteworthy margin of error
The statistical margin used to define the maximum allowable difference between biosimilar and a reference agent for psoriasis may be “unacceptably wide” to some prescribing clinicians, according to researchers. Because biosimilars are intended to have no clinically meaningful differences in safety, purity, or potency versus the approved reference drug, understanding the margin of error is “critical”, authors say.
Read more.
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.